Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

计划入组 33 人 · 首次发布于 2022 年 2 月 10 日

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

计划入组 19 人 · 首次发布于 2006 年 8 月 18 日

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

计划入组 36 人 · 首次发布于 2003 年 7 月 18 日

HLA-A2 peptides(Immutep)

HLA-A24 AFP (Adaptimmune)

HLA-A24 MAGE-A4 (Adaptimmune)

HLT, Inc.

United States

LABORATOIRE HRA PHARMA

Spain

Ela Medical Inc

United States

T-Neuro Pharma Expands Alzheimer's Blood Biomarker Assay to Include All Patients

MUSC Researchers Engineer CHAR-Tregs to Target Organ Rejection with Precision Immunosuppression

Cancer Immunotherapy Strategies Repurposed for Autoimmune Disease Treatment Show Promise in Early Studies